TD Cowen lowered the firm’s price target on Old Dominion (ODFL) to $183 from $188 and keeps a Hold rating on the shares. The firm noted they ...

TD Cowen analyst Joseph C Giordano maintained a Buy rating on Symbotic (SYM – Research Report) today and set a price target of $45.00. The ...

Fintel reports that on February 5, 2025, TD Cowen initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with a Buy ...

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

Wednesday, analysts at TD Cowen increased their price target on Fiserv (NYSE:FI) shares from $235.00 to $277.00, while retaining a Buy rating on the stock. The stock, currently trading at $229.53, has ...

Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the formal ...